FDA panel backs much-debated ALS drug in rare, 2nd review

← Back to stories
National51 articles from 20 sources across the spectrum· Updated 1491d ago

9 across the spectrum · tap a section to jump

The story so far

2 developments
  1. Sep 7, 2022FDA panel backs much-debated ALS drug in rare second review
  2. Sep 8, 2022FDA panel backs Amylyx's much-debated ALS drug

Who covered each development

No new developments

Quiet for 1491 days

Last development · Sep 8, 2022 — FDA panel backs Amylyx's much-debated ALS drug

How each side is putting it

Left

3 viewpoints
Ran by 11 outlets across the spectrum· Kokomo Tribune, Portland Press Herald, +4 more
Kokomo TribuneLean Left· 1491d ago

FDA panel backs much-debated ALS drug in rare, 2nd review

Portland Press HeraldLean Left· 1491d ago

FDA panel backs much-debated ALS drug in rare, 2nd review

Herald BulletinLean Left· 1492d ago

FDA panel backs much-debated ALS drug in rare, 2nd review

BostonLean Left· 1492d ago

FDA panel backs much-debated ALS drug in rare, 2nd review

Sioux City JournalLean Left· 1492d ago

FDA panel backs much-debated ALS drug in rare, 2nd review

St. Louis Post-DispatchLean Left· 1492d ago

FDA panel backs much-debated ALS drug in rare, 2nd review

St. Louis Post-DispatchLean Left· 1491d ago

In Rare Move, FDA Panel Gives Support to Controversial ALS Drug in 2nd Review

NBC NewsLean Left· 1491d ago

In reversal, FDA panel votes to recommend experimental ALS drug

Ran by 9 outlets across the spectrum· St. Louis Post-Dispatch, Kokomo Tribune, +1 more
St. Louis Post-DispatchLean Left· 1492d ago

ALS drug gets rare second review at high-stakes FDA meeting

Kokomo TribuneLean Left· 1492d ago

ALS drug gets rare second review at high-stakes FDA meeting

Sioux City JournalLean Left· 1492d ago

ALS drug gets rare second review at high-stakes FDA meeting

St. Louis Post-DispatchLean Left· 1492d ago

FDA Panel Skeptical of Controversial ALS Drug Ahead of Vote

Center

5 viewpoints
FOX 5 New YorkCenter· 1491d ago

FDA panel backs Amylyx's much-debated ALS drug

CBS NewsCenter· 1491d ago

FDA panel backs much-debated ALS drug in rare second review

Ran by 15 outlets· Courthouse News Service, CBS 19 Tyler, +13 more
Courthouse News ServiceCenter· 1491d ago

FDA panel backs much-debated ALS drug in rare, 2nd review

CBS 19 TylerCenter· 1491d ago

FDA panel backs much-debated ALS drug in rare, 2nd review

ABC 10 SacramentoCenter· 1491d ago

FDA panel backs much-debated ALS drug in rare, 2nd review

12News Now BeaumontCenter· 1491d ago

FDA panel backs much-debated ALS drug in rare, 2nd review

FOX 61 HartfordCenter· 1491d ago

FDA panel backs much-debated ALS drug in rare, 2nd review

MedicalXpressCenter· 1491d ago

FDA panel backs much-debated ALS drug in rare, 2nd review

WISH-TV IndianapolisLean Left· 1491d ago

FDA panel backs much-debated ALS drug in rare, 2nd review

KAGS BryanCenter· 1491d ago

FDA panel backs much-debated ALS drug in rare, 2nd review

WTHR IndianapolisCenter· 1491d ago

FDA panel backs much-debated ALS drug in rare, 2nd review

The Buffalo NewsCenter· 1491d ago

FDA panel backs much-debated ALS drug in rare, 2nd review

Omaha World-HeraldCenter· 1491d ago

FDA panel backs much-debated ALS drug in rare, 2nd review

WTOL ToledoCenter· 1491d ago

FDA panel backs much-debated ALS drug in rare, 2nd review

WFMZ AllentownCenter· 1492d ago

FDA panel backs much-debated ALS drug in rare, 2nd review

KING 5 SeattleCenter· 1492d ago

FDA panel backs much-debated ALS drug in rare, 2nd review

La Crosse TribuneCenter· 1492d ago

FDA panel backs much-debated ALS drug in rare, 2nd review

WFMZ AllentownCenter· 1492d ago

FDA panel backs much-debated ALS drug in rare, 2nd review

Ran by 2 outlets· NBC10 Philadelphia, NBC 6 South Florida
NBC10 PhiladelphiaLean Left· 1491d ago

ALS Drug Gets Support of FDA Advisers in Rare Second Review

NBC 6 South FloridaLean Left· 1491d ago

ALS Drug Gets Support of FDA Advisers in Rare Second Review

Ran by 13 outlets· NBC Los Angeles, MedicalXpress, +11 more
NBC Los AngelesLean Left· 1492d ago

ALS Drug Gets Rare Second Review at High-Stakes FDA Meeting

MedicalXpressCenter· 1492d ago

ALS drug gets rare second review at high-stakes FDA meeting

10TV ColumbusCenter· 1492d ago

ALS drug gets rare second review at high-stakes FDA meeting

FOX 43 YorkCenter· 1492d ago

ALS drug gets rare second review at high-stakes FDA meeting

Local MemphisCenter· 1492d ago

ALS drug gets rare second review at high-stakes FDA meeting

WFMZ AllentownCenter· 1492d ago

ALS drug gets rare second review at high-stakes FDA meeting

NBC 5 Dallas-Fort WorthLean Left· 1492d ago

ALS Drug Gets Rare Second Review at High-Stakes FDA Meeting

WQADCenter· 1492d ago

ALS drug gets rare second review at high-stakes FDA meeting

NBC4 WashingtonLean Left· 1492d ago

ALS Drug Gets Rare Second Review at High-Stakes FDA Meeting

NBC New YorkLean Left· 1492d ago

ALS Drug Gets Rare Second Review at High-Stakes FDA Meeting

WFMZ AllentownCenter· 1492d ago

ALS drug gets rare second review at high-stakes FDA meeting

WHAS LouisvilleCenter· 1492d ago

ALS drug gets rare second review at high-stakes FDA meeting

The Buffalo NewsCenter· 1492d ago

ALS drug gets rare second review at high-stakes FDA meeting

NBC ChicagoLean Left· 1492d ago

ALS Drug Gets Rare Second Review at High-Stakes FDA Meeting

Right

1 viewpoint
Fox NewsRight· 1491d ago

FDA panel votes to recommend Amylyx ALS drug

Ran by 9 outlets across the spectrum· MyNorthwest, Winchester Star, +1 more
MyNorthwestLean Right· 1492d ago

ALS drug gets rare second review at high-stakes FDA meeting

Winchester StarLean Right· 1492d ago

ALS drug gets rare second review at high-stakes FDA meeting

Bowling Green Daily NewsLean Right· 1492d ago

ALS drug gets rare second review at high-stakes FDA meeting

FDA panel backs much-debated ALS drug in rare, 2nd review | Slantwise